The discovery and SAR of cyclopenta[b]furans as inhibitors of CCR2.
The discovery of a novel series of cyclopenta[b]furans as CCR2 inhibitors is discussed. This series has excellent CCR2 potency and PK characteristics, and good cardiovascular safety.